Lee Rosebush Comments on Importance of Compounding Pharmacies in Pandemic Response

News / June 9, 2020

Partner Lee Rosebush is quoted in an article published by STAT on June 9, 2020. The article, “The Coronavirus Pandemic is Reigniting a Fierce Debate Over Compounded Drugs,” reports on the Food and Drug Administration’s (FDA) recent rollback of many rules regarding compounding pharmacies.

“One of the nice shining lights that came out of the global pandemic, as sad as [it is], was that the FDA is now starting to see the importance of our industry,” said Rosebush, who serves as general counsel of the Outsourcing Facility Association, which represents large-scale compounders.

Read the article (registration required).

Related Services